Lalita Ramakrishnan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 30

Top Topics

Systemic Sclerosis

Mycobacterium Tuberculosis

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Disease models & mechanisms

Nature microbiology

PLoS neglected tropical diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Marcel A Behr, Paul H Edelstein, Lalita Ramakrishnan
Rethinking the burden of latent tuberculosis to reprioritize research. Nature microbiology (2024)
Marcel A Behr, Paul H Edelstein, Lalita Ramakrishnan
Rethinking the burden of latent tuberculosis to reprioritize research. Nature microbiology 9 (5) (2024)
Naoya Yamaguchi, Hideo Otsuna, Michal Eisenberg-Bord, Lalita Ramakrishnan
An Image Processing Tool for Automated Quantification of Bacterial Burdens in Zebrafish Larvae. bioRxiv : the preprint server for biology (2024)
Marcel A Behr, Paul H Edelstein, Lalita Ramakrishnan
Rethinking the burden of latent tuberculosis to reprioritize research. Nature microbiology 9 (5) (2024)
Lalita Ramakrishnan
Redefining tuberculosis: an interview with Lalita Ramakrishnan. Disease models & mechanisms 16 (3) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Lalita Ramakrishnan
Redefining tuberculosis: an interview with Lalita Ramakrishnan. Disease models & mechanisms 16 (3) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Lalita Ramakrishnan
Redefining tuberculosis: an interview with Lalita Ramakrishnan. Disease models & mechanisms 16 (3) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Jingwen Fan, Victoria L Hale, Lindsey T Lelieveld, Laura J Whitworth, Elisabeth M Busch-Nentwich, Mark Troll, Paul H Edelstein, Timothy M Cox, Francisco J Roca, Johannes M F G Aerts, Lalita Ramakrishnan
Gaucher disease protects against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
M Alexandra Lake, Kristin N Adams, Feilin Nie, Elaine Fowler, Amit K Verma, Silvia Dei, Elisabetta Teodori, David R Sherman, Paul H Edelstein, David R Spring, Mark Troll, Lalita Ramakrishnan
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences of the United States of America 120 (7) (2023)
Francisco J Roca, Laura J Whitworth, Hiran A Prag, Michael P Murphy, Lalita Ramakrishnan
Tumor necrosis factor induces pathogenic mitochondrial ROS in tuberculosis through reverse electron transport. Science (New York, N.Y.) 376 (6600) (2022)
Morwan M Osman, Jonathan K Shanahan, Frances Chu, Kevin K Takaki, Malte L Pinckert, Antonio J Pagán, Roland Brosch, William H Conrad, Lalita Ramakrishnan
The C terminus of the mycobacterium ESX-1 secretion system substrate ESAT-6 is required for phagosomal membrane damage and virulence. Proceedings of the National Academy of Sciences of the United States of America 119 (11) (2022)
Kevin K Takaki, Francisco J Roca, Gabriele Schramm, Ruud H P Wilbers, Wannaporn Ittiprasert, Paul J Brindley, Gabriel Rinaldi, Matthew Berriman, Lalita Ramakrishnan, Antonio J Pagán
Tumor Necrosis Factor and Schistosoma mansoni egg antigen omega-1 shape distinct aspects of the early egg-induced granulomatous response. PLoS neglected tropical diseases 15 (1) (2021)
Marcel A Behr, Eva Kaufmann, Jacalyn Duffin, Paul H Edelstein, Lalita Ramakrishnan
Latent Tuberculosis: Two Centuries of Confusion. American journal of respiratory and critical care medicine 204 (2) (2021)
Laura J Whitworth, Jacob Coxon, Arjan van Laarhoven, Nguyen Thuy Thuong Thuong, Sofiati Dian, Bachti Alisjahbana, Ahmad Rizal Ganiem, Reinout van Crevel, Guy E Thwaites, Mark Troll, Paul H Edelstein, Roger F Sewell, Lalita Ramakrishnan
A Bayesian analysis of the association between Leukotriene A4 Hydrolase genotype and survival in tuberculous meningitis. eLife 10 (2021)